ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

Yang, Xiao-Mei; Wu, Zheng; Wang, Xiaoqi; Zhou, Yaoqi; Zhu, Lei; Li, Dongxue; Nie, Hui-Zhen; Wang, Ya-Hui; Li, Jun*; Ma, Xueyun*上海交通大学
BMC Pharmacology & Toxicology2022-7-22DOI: 10.1186/s40360-022-00583-5
1被引12阅读
引用收藏
分享

摘要

Background Liver fibrosis is a wound-healing response to chronic injury, featuring with excess accumulation of extracellular matrix secreted by the activated hepatic stellate cells (HSC). Disulfiram (DSF), also known as Antabuse, has been used for the treatment of alcohol addiction and substance abuse. Recently, overwhelming studies had revealed anti-cancer effects of DSF in multiple cancers, including liver cancer. But the actual effects of DSF on liver fibrosis and liver function remain unknown. Methods In this study, we evaluated the effects of low-dose DSF in CCl4- and Bile Duct Ligation (BDL)-induced hepatic fibrosis rat models. Cell proliferation was detected by using the Cell-Light (TM) EdU Apollo (R) 567 Cell Tracking Kit. Cell apoptosis was analyzed using a TdT-mediated dUTP nick end labeling (TUNEL) kit, viability was measured with Cell Counting Kit-8(CCK8). Relative mRNA expression of pro-fibrogenic was assessed using quantitative RT-PCR. The degree of liver fibrosis, activated HSCs, were separately evaluated through Sirius Red-staining, immunohistochemistry and immunofluorescence. Serum alanine aminotransferase (ALT) and asparagine aminotransferase (AST) activities were detected with ALT and AST detecting kits using an automated analyzer. Results Liver fibrosis was distinctly attenuated while liver functions were moderately ameliorated in the DSF-treated group. Activation and proliferation of primary rat HSCs isolated from rat livers were significantly suppressed by low-dose DSF. DSF also inhibited the viability of in vitro cultured rat or human HSC cells dose-dependently but had no repressive role on human immortalized hepatocyte THLE-2 cells. Interestingly, upon DSF treatment, the viability of LX-2 cells co-cultured with THLE-2 was significantly inhibited, while that of THLE-2 co-cultured with LX-2 was increased. Further study indicated that HSCs apoptosis was increased in DSF/CCl4-treated liver samples. These data indicated that DSF has potent anti-fibrosis effects and protective effects toward hepatocytes and could possibly be repurposed as an anti-fibrosis drug in the clinic. Conclusions DSF attenuated ECM remodeling through suppressing the transformation of quiet HSCs into proliferative, fibrogenic myofibroblasts in hepatic fibrosis rat models. DSF provides a novel approach for the treatment of liver fibrosis.

学科与关键词

关键词
DisulfiramLiver fibrosisHepatic stellate cellCo-culture
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
BMC Pharmacology & Toxicology
发表日期
2022-07-22
卷期
第 23 卷, 第 1 期
页码
54
DOI
10.1186/s40360-022-00583-5
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81972582]; Natural Science Foundation of Shanghai [19ZR1452500]

作者

  • Y

    Yang, Xiao-Mei (第一作者)

    shanghai canc inst · shanghai jiao tong univ

  • W

    Wu, Zheng

    shanghai canc inst · shanghai jiao tong univ

查看全部 10 位作者收起作者
  • W

    Wang, Xiaoqi

    shanghai canc inst · shanghai jiao tong univ

  • Z

    Zhou, Yaoqi

    shanghai canc inst · shanghai jiao tong univ

  • Z

    Zhu, Lei

    shanghai canc inst · shanghai jiao tong univ

  • L

    Li, Dongxue

    shanghai canc inst · shanghai jiao tong univ

  • N

    Nie, Hui-Zhen

    shanghai canc inst · shanghai jiao tong univ

  • W

    Wang, Ya-Hui

    shanghai canc inst · shanghai jiao tong univ

  • L

    Li, Jun (通讯)

    shanghai canc inst · shanghai jiao tong univ

  • M

    Ma, Xueyun (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417